BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6348011)

  • 1. Immunochemical identification of the cell surface bound leucine aminopeptidase, the target enzyme for the immunostimulant bestatin.
    Leyhausen G; Gramzow M; Zahn RK; Steffen R; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1983 Jun; 36(6):728-34. PubMed ID: 6348011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin.
    Leyhausen G; Schuster DK; Vaith P; Zahn RK; Umezawa H; Falke D; Müller WE
    Biochem Pharmacol; 1983 Mar; 32(6):1051-7. PubMed ID: 6838651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK; David PR; Lipscomb WN
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminopeptidase activity in human nasal mucosa.
    Ohkubo K; Baraniuk JN; Hohman R; Merida M; Hersh LB; Kaliner MA
    J Allergy Clin Immunol; 1998 Nov; 102(5):741-50. PubMed ID: 9819290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells.
    Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H
    Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin.
    Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP
    J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
    Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
    Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Characterization of Babesia bovis M17 Leucine Aminopeptidase and Inhibition of Babesia Growth by Bestatin.
    Aboge GO; Cao S; Terkawi MA; Masatani T; Goo Y; AbouLaila M; Nishikawa Y; Igarashi I; Suzuki H; Xuan X
    J Parasitol; 2015 Oct; 101(5):536-41. PubMed ID: 26057618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin.
    Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE
    Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bestatin, an inhibitor of cell surface proteases, in the interaction of serum with untransformed cells in culture.
    Koren R; Bercovitz H; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1981 Jan; 34(1):90-4. PubMed ID: 7251513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.
    Ino K; Goto S; Kosaki A; Nomura S; Asada E; Misawa T; Furuhashi Y; Mizutani S; Tomoda Y
    Biotherapy; 1991; 3(4):351-7. PubMed ID: 1786199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of a membrane-bound enkephalin-degrading aminopeptidase by bestatin analogs.
    Shimamura M; Hazato T; Hachisu M; Katayama T
    J Neurochem; 1984 Sep; 43(3):888-90. PubMed ID: 6431055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.
    Jösch C; Klotz LO; Sies H
    Biol Chem; 2003 Feb; 384(2):213-8. PubMed ID: 12675513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
    Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
    Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
    Kim H; Burley SK; Lipscomb WN
    J Mol Biol; 1993 Apr; 230(3):722-4. PubMed ID: 8478928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminopeptidase activities on the surface of mammalian cells.
    Aoyagi T; Suda H; Nagai M; Ogawa K; Suzuki J
    Biochim Biophys Acta; 1976 Nov; 452(1):131-43. PubMed ID: 990309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
    Imamura N; Kimura A
    Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A; Peltier CZ; Torre FJ; Hakamian N
    Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.